News | Proton Therapy | May 05, 2017

Work Starts on Belgium's First Proton Therapy Center

Proton Therapy Center ParTICLe in Leuven will feature IBA’s Proteus One system

Work Starts on Belgium's First Proton Therapy Center

May 5, 2017 — IBA announced that building works have begun on the Proton Therapy Center ParTICLe – Belgium’s first center for proton therapy. ParTICLe, short for Particle Therapy Interuniversity Center Leuven, is a clinical and scientific collaboration between five university hospitals.

Currently, Belgian patients eligible for proton therapy have to travel abroad for treatment; usually to Germany, Switzerland or France. It is expected that Belgian patients will now be able to receive proton therapy in their home country by mid-2019.

The new center will utilize IBA’s Proteus One compact intensity modulated proton therapy (IMPT) system, which is smaller, more affordable, and easier to install and operate.

Prof. Karin Haustermans, head of the Department of Radiation Oncology in UZ Leuven, said "Despite the enormous technical advances in radiation for cancer treatment, we still see too many patients who relapse or have permanent side effects. Sometimes when healthy radiation-sensitive tissues are too close to the tumor; it is almost impossible to irradiate them without compromising the quality of life of the patient. Proton therapy provides more protection to healthy tissue, and reduces the risk of secondary cancer caused by the radiation itself."

For more information: www.iba-worldwide.com

Related Content

Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Amar Kishan, M.D.

Amar Kishan, M.D.

News | Prostate Cancer | September 11, 2018
UCLA researchers have discovered that a combination of high doses of...
Videos | Radiation Therapy | September 07, 2018
A discussion with Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Gr
Boston Scientific to Acquire Augmenix Inc.
News | Patient Positioning Radiation Therapy | September 07, 2018
Boston Scientific has entered into a definitive agreement to acquire Augmenix Inc., a privately-held company which has...
Non-Canonical Strategy May Improve Cancer Radiotherapy
News | Radiation Therapy | August 29, 2018
August 29, 2018 — Although the success or failure of...
Videos | Treatment Planning | August 28, 2018
A discussion with...
Sponsored Content | Webinar | Radiation Therapy | August 28, 2018
Respiratory tumor motion often complicates the delivery of precision radiation treatment.
Tsuyama Chuo Proton Beam Center Treats First Patients With RayStation
News | Treatment Planning | August 27, 2018
Tsuyama Chuo Hospital in Okayama Prefecture, southwest Japan, has commenced clinical use of RayStation to plan pencil...
Radiation Therapy Affects Event Recall for Children With Brain Tumors
News | Radiation Therapy | August 24, 2018
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of...
Videos | Radiation Therapy | August 13, 2018
ITN Editor Dave Fornell takes a tour of some of the innovative new technologies on the expo floor at the 2018 America